Liver cancer

You are here: 

Treatments for stage C liver cancer

Targeted therapy is the standard treatment for stage C liver cancer. It uses drugs to target specific molecules (such as proteins) on the surface of cancer cells. These molecules help send signals that tell cells to grow or divide. By targeting these molecules, the drugs stop the growth and spread of cancer cells while limiting harm to normal cells. The targeted therapy drug used for stage C liver cancer is sorafenib (Nexavar).

Clinical trials

You may be asked if you want to join a clinical trial for liver cancer. Find out more about clinical trials.

Stories

Researcher Dr Michael Taylor Dr Michael Taylor is revealing genetic changes in childhood brain cancer.

Learn more

Great progress has been made

Icon - arrow

Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.

Learn more